Both in Diagnostics
VolitionRx Limited vs Myriad Genetics
Over the past year VNRX returned −97.9% and MYGN returned −18.5%; their daily moves had a correlation of 0.05.
VNRX −97.9% MYGN −18.5%Growth of $1, one year, split-adjusted
| Metric | VNRX | MYGN |
|---|---|---|
| Price | $0.1818 | $6.63 |
| Market cap | $5.5M | $634.2M |
| Today | −1.73% | +5.41% |
| 1 month | −29.0% | +56.7% |
| 6 months | −93.1% | +41.7% |
| Year to date | −96.4% | +7.8% |
| 1 year | −97.9% | −18.1% |
| Revenue growth (YoY) | −2.0% | −10.5% |
| Gross margin | 100.0% | 66.6% |
| Net margin | −1953.1% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 0.8× |
| Net cash | -$8.3M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | 82.0% |
| Short % of float | 5.1% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).